Hear all about the preliminary results of a real-life study, a new and promising therapeutical approach to HCC, the final results from FIGHT-202 and new presented data from the Phase 3 HIMALAYA Trial. In this episode, Associate Professor at Humanitas University and IRCCS Humanitas Research Hospital, Lorenza Rimassa, and Medical Doctor at BCLC group, Marco Sanduzzi Zamparelli, summarise the abstracts presented in General Session 4 - Therapy & Miscellaneous & Clinical Trials in progress during #ILCA22.
